-

AHF Protests ‘Greedy Gilead’ for Price Gouging

HIV/AIDS advocates converge at Piper Sandler Healthcare Conference in New York to expose drugmaker’s piggish practices

B-roll clip from another ' AHF "Greedy Gilead!" Protest. December 1, 2022 (World AIDS Day) Washington, DC

NEW YORK--(BUSINESS WIRE)--On Wednesday, November 29th, AIDS Healthcare Foundation (AHF) advocates will rally at Lotte New York Palace in protest of Gilead Sciences’ ongoing efforts to rack up exorbitant profits while restricting access to lifesaving medications.

The action outside the Piper Sandler Healthcare Conference in NYC is the latest in a series of efforts by AHF to draw attention to Gilead’s quiet campaign to undermine safety net providers & illegally restrict access to its lifesaving HIV and Hep C drugs.

Share

Wednesday’s action outside the 35th annual Piper Sandler Healthcare Conference is the latest in a series of escalating efforts by AHF to draw attention to Gilead’s quiet campaign to undermine safety net providers and illegally restrict access to lifesaving HIV and Hepatitis C treatments.

Since 2021, AHF has been taking on Gilead Sciences and CEO Daniel O’Day, holding more than two dozen protests in multiple cities, including Washington, DC; Miami, FL; Boston, MA; and Foster City, CA at the drugmaker’s corporate headquarters. AHF also has published full page ads in the San Francisco Chronicle and the Daily Record in New Jersey near Gilead’s new East Coast facilities, as well as posted online at Gilead.org.

WHO:

AHF Advocates and Allies

WHEN:

 

Wednesday, November 29, 2023 at 9:00 a.m. ET

WHERE:

Lotte New York Palace (Piper Sandler Healthcare Conference)

 

 

455 Madison Ave, New York, NY 10022

AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 1.9 million individuals across 45 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, visit us online at AIDShealth.org, find us on Facebook, follow us on Instagram, Twitter, and TikTok, and subscribe to our AHFter Hours podcast.

Contacts

Rasheed Gonga
(201) 241-0927 cell
rasheed.gonga@ahf.org

Industry:

AIDS Healthcare Foundation

Release Summary
AHF Protests ‘Greedy Gilead’ for Price Gouging in NYC
Release Versions
English

Contacts

Rasheed Gonga
(201) 241-0927 cell
rasheed.gonga@ahf.org

More News From AIDS Healthcare Foundation

AHF: Florida Lawmakers Reverse HIV Drug Cuts, Restoring Coverage for Thousands

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Thousands of Floridians living with HIV will keep the medication that keeps them alive, after the Florida Legislature today passed a state budget that reverses this year's cuts to the AIDS Drug Assistance Program (ADAP). The budget returns eligibility to 400 percent of the federal poverty level, brings back the medications the Department of Health had dropped, including Biktarvy, funds the program with $75 million, and adds independent oversight. "This is wha...

AHF Calls for Access and Dignity on Menstrual Health Day

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) joins the global commemoration of Menstrual Health Day with events across nearly 50 countries, highlighting the importance of reducing period stigma and expanding access to affordable menstrual products—critical steps in protecting overall health and reducing vulnerability to HIV and other sexually transmitted infections. Menstrual Health Day is observed annually on May 28. Around the world, barriers to menstrual health continue to...

Ebola Crisis Exposes Failure of Current Global Health Architecture, says AHF

LOS ANGELES--(BUSINESS WIRE)--As Uganda and the Democratic Republic of the Congo (DRC) confront a rapidly evolving Ebola outbreak, AIDS Healthcare Foundation (AHF) warns that the crisis highlights persistent weaknesses in the world’s ability to respond quickly and equitably to emerging infectious disease threats. The current outbreak involves the Bundibugyo strain of Ebola virus, for which no approved vaccines or therapeutics currently exist, heightening concerns among global health officials a...
Back to Newsroom